Which Korean drama will dominate 2026 so far?
The October 2026 slate has made one thing clear: Korean drama viewers are watching a split between broadcast powerhouses and full-season Netflix drops. Metrics favor the hospital thriller Doctor X: Mafia in White for now, but historical espionage, sports romance, and fantasy rom-coms are also carving out territory. This article tracks the shows driving ratings, chart positions, and buzz through mid-to-late October.
Doctor X ratings streak
Doctor X: Mafia in White premiered on SBS and Netflix on October 9. By mid-October it logged an 18.5 percent nationwide rating and a 20.8 percent peak, its best numbers to date. The series also took the global Netflix top spot days after launch.
Kim Ji-won plays a rule-breaking surgeon confronting mafia-style hospital networks. Her return after Queen of Tears supplies built-in international interest, while Jang Seung-jo’s addition widens the scope of ethical and criminal conflicts.
A formal broadcast review request has kept the title in Korean headlines, yet the controversy has not slowed streaming momentum abroad. So far, no other 2026 entry matches its combination of domestic share and global reach.
100 Days of Deception climb
100 Days of Deception debuted on tvN October 10. It reached 7.6 percent domestic ratings and second place on Netflix Korea within a week. The series also entered Japan’s top ten, an early sign of regional traction.
Kim Yoo-jung plays a pickpocket recruited into a 1930s independence operation, with Park Jin-young as the bilingual interpreter who becomes both ally and complication. Period detail and espionage pacing distinguish it from lighter October fare.
Pre-release criticism about historical sensitivity has shifted to discussion of on-screen chemistry. The series still trails Doctor X in raw numbers, but its upward curve keeps it in the conversation for year-end lists.
Take Charge binge numbers
Take Charge of My Heart dropped all episodes on Netflix October 9. It landed at third place on the Korea chart and sustained viewing through the full season format. Chae Soo-bin stars opposite Kim Young-kwang in a fantasy rom-com about an artificial heart and electrical superpowers.
Soo-bin had hesitated over another romantic lead role, but the supernatural twist and co-star pairing changed her mind. The lighter tone offers an alternative to the heavier medical and spy dramas dominating headlines.
Its chart position shows that full-season releases can still compete with weekly broadcast titles when casting and genre hooks align with audience demand.
Between Steps steady share
Between Steps premiered early October on ENA. It captured second place in the weekly TV top ten with a 14.57 percent audience share. Choo Young-woo and Kim So-hyun play a former swimmer and his supportive partner in a slow-burn disability romance.
The series trades high-stakes action for emotional realism and recognizable stars. Early buzz centers on its handling of physical recovery and quiet courtship rather than plot twists.
While its numbers sit below Doctor X, the show’s consistent placement signals sustained interest in grounded character stories amid louder genre entries.
Perfect Crown early benchmark
Perfect Crown led Nielsen Korea tallies earlier in the year, peaking at 13.8 percent. IU and Byeon Woo-seok starred in an alternate-history royal romance that still surfaces in “best of 2026 so far” roundups.
Its class-crossing love story and constitutional-monarchy setting gave global fans a familiar yet fresh premise. The series established a domestic benchmark that later October releases have had to measure against.
Though its run concluded months ago, streaming re-watches and awards chatter keep it visible in year-to-date comparisons.
Teach You global reach
Teach You a Lesson topped industry insider polls for social commentary blended with action. A former special-forces soldier turned substitute teacher confronts corruption in the education system.
The series led global Netflix charts for multiple weeks, showing that issue-driven stories can travel when paired with high-concept execution. Its first-place votes in a Zapzee poll underscored critical and viewer alignment.
International volume remains strong even as new October titles arrive, illustrating how earlier 2026 releases continue to shape conversations about what travels beyond Korea.
Streaming versus broadcast split
October data shows broadcast dramas still dominate raw Korean ratings, yet Netflix originals claim quicker global chart movement. Doctor X bridges both arenas; most others sit on one side or the other.
Full-season drops reward binge viewers and front-load algorithmic promotion, while weekly airings build appointment viewing and water-cooler talk. Neither model has knocked out the other this year.
Platforms are watching which October titles retain audiences after the first month, a metric that will influence 2027 renewal and licensing decisions.
Star power and genre mix
Kim Ji-won, IU, and Chae Soo-bin anchor three of the most visible projects, each bringing distinct fan bases. Their casting decisions reflect a broader industry pattern of pairing established names with genre experiments rather than straight repeats.
Medical noir, period espionage, fantasy rom-com, and disability romance now coexist on the same charts. The variety undercuts any single-trend narrative and keeps different viewer segments engaged.
Agencies are already testing similar pairings for early 2027, betting that recognizable faces plus fresh tonal shifts can replicate this year’s split success.
What happens next
Domestic ratings and global chart positions will continue to diverge as more titles enter the pipeline. Doctor X holds the strongest hand through late October, yet sustained streaming numbers or awards momentum could shift the final ranking.
Viewers outside Korea will decide whether the lighter rom-com or the heavier thrillers travel farther once awards season attention arrives. The next round of data drops in November will clarify which Korean drama truly dominates 2026.
